Drugs / fluorouraci
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02483767 Background | Jun 2015 → Nov 2016 | breast cancer | Peking Union Medical College Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fluorouraci | “fluorouraci/Anthracyclines/cyclophosphamide followed by doxetaxel or paclitaxel” NCT02483767 ↗ |